Stock News

$-0.27 EPS Expected for Cardiome Pharma Corp. (COM); Rimini Street (RMNI) Sellers Increased By 12.9% Their Shorts

Analysts expect Cardiome Pharma Corp. (TSE:COM) to report $-0.27 EPS on May, 21.They anticipate $0.01 EPS change or 3.85% from last quarter’s $-0.26 EPS. After having $-0.30 EPS previously, Cardiome Pharma Corp.’s analysts see -10.00% EPS growth. The stock decreased 1.67% or $0.05 during the last trading session, reaching $2.95. About 6,220 shares traded. Cardiome Pharma Corp. (TSE:COM) has 0.00% since May 10, 2017 and is . It has underperformed by 11.55% the S&P500.

Rimini Street Inc (NASDAQ:RMNI) had an increase of 12.9% in short interest. RMNI’s SI was 45,500 shares in May as released by FINRA. Its up 12.9% from 40,300 shares previously. With 19,400 avg volume, 2 days are for Rimini Street Inc (NASDAQ:RMNI)’s short sellers to cover RMNI’s short positions. The SI to Rimini Street Inc’s float is 0.49%. The stock decreased 0.25% or $0.02 during the last trading session, reaching $7.93. About 29,982 shares traded or 15.55% up from the average. Rimini Street, Inc. (NASDAQ:RMNI) has declined 13.56% since May 10, 2017 and is downtrending. It has underperformed by 25.11% the S&P500.

Cardiome Pharma Corp., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of patients suffering from heart diseases. The company has market cap of $102.86 million. It offers BRINAVESS ) for the conversion of recent onset atrial fibrillation to sinus rhythm in adults; and AGGRASTAT, a reversible GP IIb/IIIa inhibitor for use in acute coronary syndrome patients. It currently has negative earnings. The firm also provides ESMOCARD and ESMOCARD LYO short-acting beta-blockers used to control rapid heart rate; XYDALBA, a semi-synthetic lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections; and TREVYENT for the treatment of pulmonary arterial hypertension.

Rimini Street, Inc. provides enterprise software support services. The company has market cap of $471.13 million. It offers enterprise software support services for Siebel, PeopleSoft, JD Edwards, Oracle E-Business Suite, Oracle Database, Hyperion, Oracle Retail, Oracle Fusion Middleware, SAP, and BusinessObjects software. It currently has negative earnings. The firm provides support services program features, such as product support, security support, risk avoidance, technology support, innovation and roadmap, account management, and onboarding and archiving services, as well as global tax, legal, and regulatory update services.

More recent Rimini Street, Inc. (NASDAQ:RMNI) news were published by: Business.Financialpost.com which released: “Rimini Street Launches New Solutions that Further Extend the Life and Value of Enterprise Software as a Foundation …” on April 24, 2018. Also Businesswire.com published the news titled: “Rimini Street to Report First Quarter 2018 Financial Results on May 10, 2018” on April 26, 2018. Businesswire.com‘s news article titled: “Corona Corporation Switches to Rimini Street for Oracle EBS Support” with publication date: April 17, 2018 was also an interesting one.

Leave a Reply

Your email address will not be published. Required fields are marked *